the effect of regenerative biomaterial on bladder symptoms in patients with transurethral resection of bladder tumor

A randomized controlled trial, prospective study to investigate the effect of regenerative biomaterial on bladder symptoms in patients with transurethral resection of bladder tumor

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0009775

Enrollment

Registered

2024-09-10

Start date

2024-07-31

Completion date

Unknown

Last updated

2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Blad-Care™ The above product has obtained medical device item approval from the Ministry of Food and Drug Safety for its function of rebuilding, supplementing, and protecting the dama

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Those scheduled to undergo transurethral resection of Bladder tumor

Exclusion criteria

Exclusion criteria: Research subjects under 19 years of age and over 80 years of age

Design outcomes

Primary

Measure	Time frame
Overactive Bladder Symptom Questionnaire (OABSS) and Pain (NRS)	—

Secondary

Measure	Time frame
International Prostate Symptom Score (IPSS), Bladder Cancer Recurrence	—

Countries

Korea, Republic of

Contacts

Public ContactSe Young Choi

Chung-Ang University

alse3025@hanmail.net+82-2-6299-1810

Outcome results